Genelux (GNLX) Depreciation & Amortization (CF) (2022 - 2026)

Genelux's (GNLX) quarterly Depreciation & Amortization (CF) came in at $9000.0 in Q1 2026, down 84.75% year-on-year from $59000.0 in Q1 2025, and down 85.0% quarter-over-quarter from $60000.0 in Q4 2025.

Genelux (GNLX) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

Genelux's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $9000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 84.75% year-over-year to $9000.0 in Q1 2026; TTM through Mar 2026 was $193000.0, a 8.1% decrease from a year earlier, with the FY2025 full-year figure at $244000.0, up 3.83% from the prior year.
  • Depreciation & Amortization (CF) fell to $9000.0 in Q1 2026 per GNLX's latest filing, from $60000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $138000.0 in Q1 2022 and bottomed at $9000.0 in Q1 2026.
  • The 5-year median for Depreciation & Amortization (CF) is $63000.0 (2025), against an average of $84133.3.
  • Across the five-year window, Depreciation & Amortization (CF) soared 65.79% in 2025 and tumbled 84.75% in 2026, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $138000.0 in 2022, then sank by 31.16% to $95000.0 in 2023, then plunged by 40.0% to $57000.0 in 2024, then advanced by 5.26% to $60000.0 in 2025, then tumbled by 85.0% to $9000.0 in 2026.
  • Per Business Quant, the three latest GNLX Depreciation & Amortization (CF) figures stand at $9000.0 (Q1 2026), $60000.0 (Q4 2025), and $61000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 196,658.72
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 41.14 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 2.20 Mn
10 Genelux 129.36 Mn 129.36 Mn - 9,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 9,000.00
Mar 31, 2026 9,000.00
Dec 31, 2025 60,000.00
Dec 31, 2025 60,000.00
Sep 30, 2025 61,000.00
Sep 30, 2025 61,000.00
Jun 30, 2025 63,000.00
Jun 30, 2025 63,000.00
Mar 31, 2025 59,000.00
Mar 31, 2025 59,000.00
Dec 31, 2024 57,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 56,000.00
Sep 30, 2024 56,000.00
Jun 30, 2024 38,000.00
Jun 30, 2024 38,000.00
Mar 31, 2024 84,000.00
Mar 31, 2024 84,000.00
Dec 31, 2023 95,000.00
Dec 31, 2023 95,000.00